Pelago Bioscience AB Revenue and Competitors

At Pelago Bioscience, we’re here to help you make faster, better-informed decisions in drug discovery. In 2010, our founders began to develop our proprietary CETSA® (Cellular Thermal Shift Assay) technology, publishing a seminal research paper in Science 2013. Since then, Pelago Bioscience has become the leading CRO providing actionable, biologically relevant insights at the pre-clinical stage.Unlike traditional methods, CETSA gives you a reliable picture of drug-target interactions, ensuring that what you see in cells translates to patients.\nOur services rest on four pillars:\n•\tCertainty in Biological Relevance: CETSA’s physiological approach helps minimize late-stage risks.\n•\tFast & Early Confidence: We deliver actionable insights in just 10 days-10 weeks (service dependent), eliminating unnecessary complexities so you can make decisions faster.\n•\tInsights & Progress: Our data supports compound prioritization and predicts future research steps, reducing project costs.\n•\tExtended Team Support: We work as your dedicated partner, designing fit-for-purpose studies that align with your goals.\nWith Pelago Bioscience, you gain more than just data; you gain a trusted partner in your discovery journey.